This bid is closed — responses were due August 27, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for the acquisition of an Element Biosciences AVITI24 Sequencing System to enhance the shared research capabilities of the National Cancer Institute's Center for Cancer Research.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Element Biosciences AVITI24 Sequencing System
1
each
$350,000.00
$350,000.00
Medical
Estimated Bid Value
$350,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds the 2 documents, contracting-officer contacts and AI response outlines.